We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

0 hedge funds and large institutions have $0 invested in INTERLEUKIN GENETICS INC in 2018 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $1K → $0 (-$1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CL
CPWM LLC
Washington
-$1K

ILI Hedge Fund Activity: Q1 2018 in Review

0 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q1 2018, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ILI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was CPWM LLC, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held INTERLEUKIN GENETICS INC (ILI) as of Q1 2018, down from 1 in Q4 2017.
  • Funds reported $0 of INTERLEUKIN GENETICS INC stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new INTERLEUKIN GENETICS INC positions in Q1 2018 and 1 closed out, a net change of -1 holder.
  • The largest INTERLEUKIN GENETICS INC seller in Q1 2018 was CPWM LLC, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2018.